Stocks and Investing
Stocks and Investing
Wed, November 9, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, November 8, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Michael King Maintained (BMEA) at Strong Buy with Decreased Target to $22 on, Nov 8th, 2022
Michael King of EF Hutton, Maintained "Biomea Fusion, Inc." (BMEA) at Strong Buy with Decreased Target from $27 to $22 on, Nov 8th, 2022.
Michael has made no other calls on BMEA in the last 4 months.
There is 1 other peer that has a rating on BMEA. Out of the 1 peers that are also analyzing BMEA, 0 agree with Michael's Rating of Hold.
This is the rating of the analyst that currently disagrees with Michael
- Joseph Pantginis of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $37 on, Monday, October 31st, 2022
Contributing Sources